These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 26521278)

  • 1. Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?
    Paesmans M
    Eur Respir J; 2015 Nov; 46(5):1259-61. PubMed ID: 26521278
    [No Abstract]   [Full Text] [Related]  

  • 2. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma.
    Takuwa T; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Neri S; Hasegawa S; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3943-52. PubMed ID: 22669454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Sonic hedgehog signaling proteins is related to the favorable outcome, EGFR mutation, and lepidic predominant subtype in primary lung adenocarcinoma.
    Kim JE; Kim H; Choe JY; Sun P; Jheon S; Chung JH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S570-6. PubMed ID: 23709101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.
    Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
    Eur J Cardiothorac Surg; 2011 May; 39(5):763-8. PubMed ID: 20864350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
    Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
    World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.
    Tailor TD; Schmidt RA; Eaton KD; Wood DE; Pipavath SN
    J Thorac Imaging; 2015 Sep; 30(5):308-13. PubMed ID: 26258598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma.
    Moon Y; Sung SW; Lee KY; Kim YK; Park JK
    World J Surg Oncol; 2016 Feb; 14(1):37. PubMed ID: 26879575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low papillary structure in lepidic growth component of lung adenocarcinoma: a unique histologic hallmark of aggressive behavior.
    Fukutomi T; Hayashi Y; Emoto K; Kamiya K; Kohno M; Sakamoto M
    Hum Pathol; 2013 Sep; 44(9):1849-58. PubMed ID: 23648380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma.
    Yotsukura M; Yasuda H; Shigenobu T; Kaseda K; Masai K; Hayashi Y; Hishida T; Ohtsuka T; Naoki K; Soejima K; Betsuyaku T; Asamura H
    Lung Cancer; 2017 Jul; 109():45-51. PubMed ID: 28577949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
    Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
    Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to chemotherapy/tyrosine kinase inhibitors of mucinous lepidic adenocarcinoma should be tested in a phase III trial?
    Cadranel J; Wislez M; Langlais A; Morin F; Zalcman G
    Eur Respir J; 2016 Jun; 47(6):1890-1. PubMed ID: 27246084
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimally invasive adenocarcinomas of the lung.
    Dacic S
    Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.